Clinical and genetic features of Epstein‐Barr virus‐triggered late‐onset primary hemophagocytic lymphohistiocytosis: Ten pedigrees study

Lili Gao,Li Yang,Liang Huang,Yi Xiao,Jinniu Deng,Miao Zheng,Hui Luo,Lijun Jiang,Min Xiao,Chunrui Li,Jianfeng Zhou

DOI: https://doi.org/10.1002/ctm2.393

IF: 8.554

2021-05-28

Clinical and Translational Medicine

Abstract:<header class="article-table-caption"><span class="table-caption__label">TABLE 1. </span>Clinical and laboratory characteristics of 10 EBV-triggered late-onset primary HLH cases </header><table class="table article-section__table"><thead><tr><th class="bottom-bordered-cell left-aligned">Case 1</th><th class="bottom-bordered-cell left-aligned">Case 2</th><th class="bottom-bordered-cell left-aligned">Case 3</th><th class="bottom-bordered-cell left-aligned">Case 4</th><th class="bottom-bordered-cell left-aligned">Case 5</th><th class="bottom-bordered-cell left-aligned">Case 6</th><th class="bottom-bordered-cell left-aligned">Case 7</th><th class="bottom-bordered-cell left-aligned">Case 8</th><th class="bottom-bordered-cell left-aligned">Case 9</th><th class="bottom-bordered-cell left-aligned">Case 10</th><th class="bottom-bordered-cell left-aligned">Median (range)</th></tr></thead><tbody><tr><td class="right-bordered-cell left-aligned">Gender</td><td class="left-aligned">Female</td><td class="left-aligned">Female</td><td class="left-aligned">Female</td><td class="left-aligned">Female</td><td class="left-aligned">Female</td><td class="left-aligned">Male</td><td class="left-aligned">Male</td><td class="left-aligned">Female</td><td class="left-aligned">Male</td><td class="left-aligned">Female</td><td class="left-aligned">–</td></tr><tr><td class="right-bordered-cell left-aligned">Age at onset (y), HLH</td><td class="left-aligned">14</td><td class="left-aligned">18</td><td class="left-aligned">25</td><td class="left-aligned">45</td><td class="left-aligned">12</td><td class="left-aligned">25</td><td class="left-aligned">21</td><td class="left-aligned">18</td><td class="left-aligned">32</td><td class="left-aligned">13</td><td class="left-aligned">22.3 (12–45)</td></tr><tr><td class="right-bordered-cell left-aligned">Fever (℃)</td><td class="left-aligned">40.0</td><td class="left-aligned">41.0</td><td class="left-aligned">39.2</td><td class="left-aligned">39.8</td><td class="left-aligned">39.0</td><td class="left-aligned">39.5</td><td class="left-aligned">39.6</td><td class="left-aligned">39.2</td><td class="left-aligned">39.4</td><td class="left-aligned">38.6</td><td class="left-aligned">39.5 (39–41)</td></tr><tr><td class="right-bordered-cell left-aligned">Neutrophils, 10⁹/L </td><td class="left-aligned">0.3</td><td class="left-aligned">0.2</td><td class="left-aligned">0.8</td><td class="left-aligned">0.1</td><td class="left-aligned">0.6</td><td class="left-aligned">0.1</td><td class="left-aligned">0.7</td><td class="left-aligned">0.9</td><td class="left-aligned">0.6</td><td class="left-aligned">0.8</td><td class="left-aligned">0.5 (0.1–0.9)</td></tr><tr><td class="right-bordered-cell left-aligned">Hemoglobin, g/L</td><td class="left-aligned">64.0</td><td class="left-aligned">88.0</td><td class="left-aligned">88</td><td class="left-aligned">122.0</td><td class="left-aligned">96.0</td><td class="left-aligned">98.0</td><td class="left-aligned">99.0</td><td class="left-aligned">86.0</td><td class="left-aligned">64.0</td><td class="left-aligned">76.0</td><td class="left-aligned">88.1 (64–122)</td></tr><tr><td class="right-bordered-cell left-aligned">Platelets, 10⁹/L </td><td class="left-aligned">35.0</td><td class="left-aligned">14.0</td><td class="left-aligned">32</td><td class="left-aligned">29.0</td><td class="left-aligned">90.0</td><td class="left-aligned">25.0</td><td class="left-aligned">44.0</td><td class="left-aligned">64.0</td><td class="left-aligned">9.0</td><td class="left-aligned">218.0</td><td class="left-aligned">56.0 (14–90)</td></tr><tr><td class="right-bordered-cell left-aligned">ALT index <a class="noteLink scrollableLink" href="#ctm2393-tbl1-note-0002_9">*</a><span class="footNotePopup"><span><span class="number">* </span>ALT index, patient's ALT/upper normal limit of ALT;<br/></span></span></td><td class="left-aligned">6.8</td><td class="left-aligned">11.5</td><td class="left-aligned">5.1</td><td class="left-aligned">1.2</td><td class="left-aligned">1.6</td><td class="left-aligned">2.2</td><td class="left-aligned">2.3</td><td class="left-aligned">5.5</td><td class="left-aligned">3.2</td><td class="left-aligned">10.0</td><td class="left-aligned">5.0 (1.2–11.5)</td></tr><tr><td class="right-bordered-cell left-aligned">AST index <a class="noteLink scrollableLink" href="#ctm2393-tbl1-note-0003_10">**</a><span class="footNotePopup"><span><span class="number">** </span>AST index, patient's AST/upper normal limit of AST;<br/></span></span></td><td class="left-aligned">28.0</td><td class="left-aligned">24.0</td><td class="left-aligned">6.2</td><td class="left-aligned">4.2</td><td class="left-aligned">1.5</td><td class="left-aligned">2.2</td><t <p>-Abstract Truncated-</p>

oncology,medicine, research & experimental